← All organizations
Highest phase reached
Phase 1
First clinical trial
Jun 20, 2023Last known activity
Jun 20, 2023
Acquired by AbbVie on Jun 28, 2024
Timeline
2010s
- Jan 1, 2018
Celsius Therapeutics— Founded
2020s
- Jun 28, 2024
AbbVie— Acquired By
Drugs by trial phase (1 distinct, 1 trials)
Phase 1 (1 own, 0 via acquisition)
Recent trials (2)
- NCT05901883Lead sponsorPhase 1Jun 20, 2023
- NCT05901883Study directorPhase 1Jun 20, 2023
Details
- Founded
- Cambridge, MA, US Jan 1, 2018
- Last known activity
- Jun 20, 2023